APAC Apheresis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Asia Pacific Apheresis Equipment Market and the market is segmented by Product, Indication (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Indications), Procedure, and Geography. The market provides the value (in USD million) for the above-mentioned segments.

APAC Apheresis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia Pacific Apheresis Market Size

View Global Report
Asia Pacific Apheresis Market_1
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 0.82 Billion
Market Size (2030) USD 1.35 Billion
CAGR (2025 - 2030) 10.57 %

Major Players

Asia Pacific Apheresis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia Pacific Apheresis Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Asia Pacific Apheresis Market Analysis

The Asia Pacific Apheresis Market size is estimated at USD 0.82 billion in 2025, and is expected to reach USD 1.35 billion by 2030, at a CAGR of 10.57% during the forecast period (2025-2030).

The major factors contributing to the growth of the Asia Pacific Apheresis market are increasing disease burden, the rise in demand for Blood Component Technology and associated safety, and technological advancements in the development of new apheresis techniques. However, factors such as high capital investment and costs associated with apheresis procedures are expected to restrain the market.

Apheresis Services have now become a popular mode of treatment for multiple complex immune disorders, and there has been a remarkable change in the scenario pertaining to therapeutic apheresis in Asia-Pacific. With the increasing number of diseases and accident cases, along with technological advancements in Apheresis Equipment, the market studied is expected to experience a boost during the forecast period. Additionally, the rising number of government initiatives, blood donation camps, and increasing awareness about Donor Apheresis are factors responsible for the growth of the market studied. Apheresis technology is expensive. It is also technically and medically demanding.

Asia Pacific Apheresis Industry Overview

The Asia Pacific Apheresis market is moderately competitive and consists of several major players. In terms of market share, a few major players currently dominate the apheresis market, particularly in the area of Apheresis Devices and equipment. With the increasing prevalence of diseases in the Asia Pacific region, the usage of apheresis and the demand for Apheresis Machines is expected to rise, thereby more players are expected to enter the market. Some of the major players in the market are Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation and Terumo Corporation, who offer a wide range of Apheresis Equipment and services.

Asia Pacific Apheresis Market Leaders

  1. Asahi Kasei Corporation

  2. B. Braun Melsungen AG

  3. Cerus Corporation

  4. Kaneka Corporation

  5. Terumo Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Asia Pacific Apheresis Market_4
Need More Details on Market Players and Competiters?
Download PDF

Asia Pacific Apheresis Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Disease Burden in Asia
    • 4.2.2 Rise in Demand for Blood Components and Associated Safety
    • 4.2.3 Technological Advancement in the Development of New Apheresis Techniques
  • 4.3 Market Restraints
    • 4.3.1 High Capital Investment and Cost Associated with Apheresis Procedures
    • 4.3.2 Risk of Blood Contamination
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Devices
    • 5.1.2 Disposables
  • 5.2 By Indication
    • 5.2.1 Renal Disorders
    • 5.2.2 Hematological Disorders
    • 5.2.3 Neurological Disorders
    • 5.2.4 Autoimmune Disorders
    • 5.2.5 Other Indications
  • 5.3 By Procedure
    • 5.3.1 Plasmapheresis
    • 5.3.2 Plateletpheresis
    • 5.3.3 Erythrocytapheresis
    • 5.3.4 Leukapheresis
    • 5.3.5 Other Procedures
  • 5.4 Geography
    • 5.4.1 China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 Australia
    • 5.4.5 South Korea
    • 5.4.6 Rest of Asia Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Asahi Kasei Corporation
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Cerus Corporation
    • 6.1.4 Kaneka Corporation
    • 6.1.5 Terumo Corporation
    • 6.1.6 Fresenius SE & Co. KGaA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia Pacific Apheresis Industry Segmentation

Apheresis is a medical technique, where the blood of an individual, either a donor or patient, is passed through an apparatus that separates a particular constituent and returns the rest of the blood to the circulatory system. This is an extracorporeal therapy.

By Product Devices
Disposables
By Indication Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Other Indications
By Procedure Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Procedures
Geography China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Need A Different Region or Segment?
Customize Now

Asia Pacific Apheresis Market Research FAQs

How big is the Asia Pacific Apheresis Market?

The Asia Pacific Apheresis Market size is expected to reach USD 0.82 billion in 2025 and grow at a CAGR of 10.57% to reach USD 1.35 billion by 2030.

What is the current Asia Pacific Apheresis Market size?

In 2025, the Asia Pacific Apheresis Market size is expected to reach USD 0.82 billion.

Who are the key players in Asia Pacific Apheresis Market?

Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation and Terumo Corporation are the major companies operating in the Asia Pacific Apheresis Market.

What years does this Asia Pacific Apheresis Market cover, and what was the market size in 2024?

In 2024, the Asia Pacific Apheresis Market size was estimated at USD 0.73 billion. The report covers the Asia Pacific Apheresis Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia Pacific Apheresis Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

APAC Apheresis Industry Report

Statistics for the 2025 Asia Pacific Apheresis market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Apheresis analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.